Background: Although studies in recent years have explored the impact of gut microbiota on various sleep characteristics, the interaction between gut microbiota and insomnia remains unclear.
Aims: We aimed to evaluate the mutual influences between gut microbiota and insomnia.
Methods: We conducted Mendelian randomisation (MR) analysis using genome-wide association studies datasets on insomnia (N=386 533), gut microbiota data from the MiBioGen alliance (N=18 340) and the Dutch Microbiome Project (N=8208). The inverse variance weighted (IVW) technique was selected as the primary approach. Then, Cochrane's Q, Mendelian randomization-Egger (MR-Egger) and MR Pleiotropy RESidual Sum and Outlier test (MR-PRESSO) tests were used to detect heterogeneity and pleiotropy. The leave-one-out method was used to test the stability of the MR results. In addition, we performed the Steiger test to thoroughly verify the causation.
Results: According to IVW, our results showed that 14 gut bacterial taxa may contribute to the risks of insomnia (odds ratio (OR): 1.01 to 1.04), while 8 gut bacterial taxa displayed a protective effect on this condition (OR: 0.97 to 0.99). Conversely, reverse MR analysis showed that insomnia may causally decrease the abundance of 7 taxa (OR: 0.21 to 0.57) and increase the abundance of 12 taxa (OR: 1.65 to 4.43). Notably, the genus Odoribacter showed a significant positive causal relationship after conducting the Steiger test. Cochrane's Q test indicated no significant heterogeneity between most single-nucleotide polymorphisms. In addition, no significant level of pleiotropy was found according to MR-Egger and MR-PRESSO.
Conclusions: Our study highlighted the reciprocal relationships between gut microbiota and insomnia, which may provide new insights into the treatment and prevention of insomnia.
Keywords: Causality; Mendelian Randomization Analysis.
Copyright © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.